Quantum
Home > Boards > US Listed > Medical - Healthcare >

Gilead Sciences, Inc. (GILD)

GILD RSS Feed
Add GILD Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 11/9/2018 10:54:22 AM - Followers: 109 - Board type: Free - Posts Today: 0


GILD Investor Relations

http://www.otcmarkets.com/stock/GILD/quote
http://www.otcmarkets.com/stock/GILD/profile
Contact Info
  • 333 Lakeside Drive
    Foster City, CA 94404
GILD Security Details
Share Structure
  Market Value1 $94,343,029,244 a/o Dec 30, 2016
  Authorized Shares Not Available
  Outstanding Shares 1,317,456,071 a/o Oct 31, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float Not Available
  Par Value 0.001
Transfer Agent(s)
BNYMellon Shareowner Services
Shareholders
Shareholders of Record 363 a/o Feb 24, 2016
Corporate Actions
  Ex. Date Record Date Pay Date
Dividend (0.47) Dec 13, 2016 Dec 15, 2016 Dec 29, 2016
Dividend (0.47) Sep 14, 2016 Sep 16, 2016 Sep 29, 2016
Dividend (0.47) Jun 14, 2016 Jun 16, 2016 Jun 29, 2016
 
Dividends are not adjusted for stock splits
Security Notes
  • Capital Change=shs increased by 2 for 1 split. Ex-date=03/08/2002. Rec date=02/14/2002. Pay date=03/07/2002.
    Latest Addt'l Issue=2-96 4,000,000 shs at $37.75 by Robertson, Stephens & Co. et al.
    New Issue=1-92 5,000,000 shs at $15 by Robertson, Stephens & Co., et al.
    Capital Change=shs increased by 2 for 1 split. Ex-date=02/22/2001. Rec date=02/02/2001. Pay date=02/21/2001.
    Capital Change=shs increased by 2 for 1 split. Ex-date=09/07/2004. Rec date=08/12/2004. Pay date=09/03/2004.
    Capital Change=shs increased by 2 for 1 split Ex-date=06/25/2007. Rec date=05/24/2007. Pay date=06/22/2007.
    Capital Change=shs increased by 2 for 1 split. Ex-date=01/28/2013. Rec date=01/07/2013. Pay date=01/25/2013.

    http://finviz.com/quote.ashx?t=GILD&ty=c&ta=1&p=d
    http://finviz.com/ ;



  •  
***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.









     
 
Short Selling Data
Short Interest 19,440,457 (-7.51%)
Nov 30, 2010
Significant Failures to Deliver No


 
Quantum
GILD
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GILD News: Statement of Changes in Beneficial Ownership (4) 11/13/2018 05:01:07 PM
GILD News: Confidential Treatment Order (ct Order) 11/13/2018 09:15:33 AM
GILD News: Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27 11/12/2018 05:01:00 PM
GILD News: Gilead Announces Positive Phase 2 Results for GS-9674 in Primary Sclerosing Cholangitis (PSC) at The Liver Meeting® 2018 11/09/2018 08:00:00 AM
GILD News: Gilead Presents Latest Data from Viral Hepatitis Research Programs at The Liver Meeting® 2018 11/09/2018 08:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2783  Sticky Note GILD 3Q18 results—HCV sales=$902M,-10% QoQ: DewDiligence 10/25/18 05:05:27 PM
#2788   GILD’s AASLD lineups… DewDiligence 11/09/18 10:54:22 AM
#2786   ASH abstracts https://ash.confex.com/ash/2018/webprogram/Paper117017.html https: jondoeuk 11/03/18 06:37:20 PM
#2785   GILD -5% on UnitedHealthcare’s incentive for patients to DewDiligence 10/31/18 08:18:38 PM
#2784   GILD 3Q18 CC transcript: DewDiligence 10/26/18 10:55:32 AM
#2783   GILD 3Q18 results—HCV sales=$902M,-10% QoQ: DewDiligence 10/25/18 05:05:27 PM
#2781   Dividend($0.57) and earnings PRs: north40000 10/25/18 04:15:25 PM
#2780   Mavyret’s US new-patient share=53.4%—the highest-ever weekly figure—in th DewDiligence 10/12/18 09:10:20 AM
#2779   GILD will launch Harvoni/Epclusa authorized generics for US DewDiligence 09/24/18 10:00:42 AM
#2778   GILD licenses gene-editing approach to HBV from (private) DewDiligence 09/12/18 11:31:45 AM
#2777   GILD News: Confidential Treatment Order (ct Order) 08/16/2018 05:17:29 PM mick 08/18/18 11:35:59 AM
#2776   GILD News: Gilead Sciences Announces Executive Promotions 08/14/2018 05:00:00 PM mick 08/18/18 11:35:52 AM
#2775   GILD News: Statement of Changes in Beneficial Ownership mick 08/18/18 11:35:38 AM
#2774   GILD News: Current Report Filing (8-k) 08/07/2018 03:52:32 PM mick 08/18/18 11:35:21 AM
#2773   GILD News: Quarterly Report (10-q) 08/06/2018 04:20:27 PM mick 08/18/18 11:35:04 AM
#2772   Gilead Sciences, Inc (GILD) mick 08/18/18 11:34:27 AM
#2771   AH filing yesterday: north40000 08/17/18 09:30:28 AM
#2770   https://www.fiercepharma.com/pharma/louisiana-seeking-comments-netflix-model-for north40000 08/17/18 03:29:11 AM
#2769   Transcript of GILD 2Q18 CC: DewDiligence 07/26/18 11:16:41 AM
#2767   GILD 2Q18 CC slides: DewDiligence 07/25/18 05:10:25 PM
#2766   Curious you would say[muse] that...what about HIV, CAR-T(with north40000 07/25/18 05:08:53 PM
#2765   Musings on John Milligan’s departure: DewDiligence 07/25/18 04:57:49 PM
#2764   CEO, John Milligan leaving at year-end: DewDiligence 07/25/18 04:39:55 PM
#2763   GILD 2Q18 results—total HCV sales $1.0B—(-5% QoQ): DewDiligence 07/25/18 04:39:17 PM
#2762   FDA approves Symtuza for HIV: #msg-142267996. DewDiligence 07/17/18 06:29:07 PM
#2761   Thanks. Very interesting article. wshaw14 06/10/18 04:32:49 PM
#2760   https://www.bloomberg.com/news/articles/2018-06-04/billions-of-fighting-cells-cl north40000 06/06/18 04:36:27 AM
#2759   Epclusa approved in China: DewDiligence 05/30/18 10:19:17 AM
#2758   Weird. Pharma. Didn’t participate. Imun. Hopeful1037 05/21/18 05:02:15 PM
#2757   http://www.otcmarkets.com/stock/GILD mick 05/20/18 07:59:01 PM
#2756   IMHO Gilead is a company with smart leadership wshaw14 05/17/18 12:11:43 AM
#2755   They want to cure AIDS. fink 05/16/18 11:49:19 PM
#2754   Gilead is smart. Keep only what they can wshaw14 05/14/18 10:55:58 PM
#2753   Dew, just one question. Better than a cure? wshaw14 05/06/18 01:35:52 AM
#2752   Lol, anybody thinking HepC is the way to wshaw14 05/06/18 01:32:44 AM
#2751   If you think giving the drug away below fink 05/02/18 11:21:48 PM
#2750   Today's trade off was a mix of data joanne4trade 05/02/18 12:09:30 PM
#2749   Save the rant! Today's selloff is occurring because DewDiligence 05/02/18 10:19:54 AM
#2748   Figures when you have a pharma Company fink 05/02/18 10:09:18 AM
#2747   Transcript of GILD 1Q18 CC: DewDiligence 05/02/18 09:59:39 AM
#2746   GILD 1Q18 CC slides: DewDiligence 05/01/18 04:58:45 PM
#2745   GILD -5%/AH on 1Q18 results—HCV sales=$1.05B: DewDiligence 05/01/18 04:09:04 PM
#2744   Astellas Announces Sale of Certain Agensys Research Facilities wshaw14 04/19/18 06:11:57 AM
#2743   Glad I sold when I did. I will wshaw14 04/12/18 06:53:09 AM
#2742   http://www.stockscores.com/charts/charts/?ticker=GILD mick 04/07/18 02:03:57 PM
#2741   MYL launches two HIV FDCs in US market: #msg-138972875. DewDiligence 03/02/18 10:53:49 AM
#2740   http://www.barchart.com/detailedquote/stocks/GILD mick 02/28/18 12:32:08 PM
#2739   In the second half of 2018, looking back jones99 02/19/18 04:16:31 AM
#2738   https://www.reuters.com/article/gilead-sciences-fda/update-1-u-s-fda-approves-gi wshaw14 02/07/18 05:28:47 PM
#2737   FDA approves Biktarvy—an FDC of Bictegravir/TAF/Emtriva: DewDiligence 02/07/18 02:47:27 PM
#2736   GILD 4Q17 CC transcript: DewDiligence 02/07/18 08:45:11 AM
PostSubject